To evaluate the comparative bioavailability of a single-dose of the investigational oral pediatric minitablet formulation of MK-1439, 0.8 mg [100 mg total dose] compared to the adult formulation of MK-1439 tablets, 100 mg in healthy adult male and female subjects under fasted conditions.